LETROZOLE

62442 reported adverse events

Drug classes: Aromatase Inhibitor [EPC]

These side effects are most commonly reported by patients taking LETROZOLE:

# Side effect Count
0 FATIGUE 7561
1 NAUSEA 5594
2 NEUTROPENIA 5295
3 DIARRHOEA 4792
4 MALIGNANT NEOPLASM PROGRESSION 4614
5 ARTHRALGIA 4046
6 WHITE BLOOD CELL COUNT DECREASED 3845
7 ALOPECIA 3711
8 PAIN 3097
9 ASTHENIA 3034
See all common reactions for LETROZOLE

LETROZOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PIK3CA-ACTIVATED MUTATION 181 0.5452
1 HORMONE RECEPTOR POSITIVE HER2 NEGATIVE BREAST CANCER 156 0.4699
2 CARBOHYDRATE ANTIGEN 15-3 INCREASED 304 0.3995
3 CARBOHYDRATE ANTIGEN 27.29 INCREASED 42 0.2800
4 HORMONE RECEPTOR POSITIVE BREAST CANCER 60 0.2206
5 AMAUROSIS FUGAX 235 0.2182
6 METASTASES TO CHEST WALL 67 0.1931
7 BREAST CANCER METASTATIC 2035 0.1893
8 METASTASES TO THORAX 45 0.1779
9 TUMOUR MARKER ABNORMAL 56 0.1692
See all enriched reactions for LETROZOLE